RYM 2.94% $4.55 ryman healthcare limited ordinary shares

Ann: RELINT: RYM: Disclosure of Director's Relevant Interests

  1. lightbulb Created with Sketch. 2
    • Release Date: 28/05/15 16:07
    • Summary: RELINT: RYM: Disclosure of Director's Relevant Interests
    • Price Sensitive: No
    • Download Document  2.71KB
    					RYM
    28/05/2015 16:07
    RELINT
    NOT PRICE SENSITIVE
    REL: 1607 HRS Ryman Healthcare Limited
    
    RELINT: RYM: Disclosure of Director's Relevant Interests
    
    Disclosure of acquisition or disposal of relevant
    interest by director or senior manager
    
    Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
    
    To: NZX Limited
    And;
    Name of Listed Issuer: Ryman Healthcare Limited
    
    Date this disclosure made: 28 May 2015
    Date of last disclosure: 25 November 2014
    
    Director(s) or senior manager(s) giving disclosure
    Full name(s): Douglas Alexander McKay
    Name of listed issuer: Ryman Healthcare Limited
    Name of related body corporate (if applicable): N/A
    Position held in listed issuer: Director
    
    Summary of acquisition or disposal of relevant interest (excluding specified
    derivatives)
    
    Class of affected quoted financial products: Ordinary shares in Ryman
    Healthcare Limited (NZX security code RYM)
    
    Nature of the affected relevant interest(s): Custodial Services Limited holds
    the shares as custodian for the McKay Family Trust Partnership, of which
    Douglas Alexander McKay is a beneficial owner.
    For that relevant interest,--
    (a) number held in class before acquisition or disposal: 6,000 ordinary
    shares
    (b) number held in class after acquisition or disposal: 24,800 ordinary
    shares
    (c) current registered holder(s): Unknown
    (d) registered holder(s) once transfers are registered: Custodial Services
    Limited
    
    Details of transactions giving rise to acquisition or disposal
    Total number of transactions to which notice relates: Two
    Details of the transactions requiring disclosure:
    (1) Acquisition of 12,500 ordinary shares in an on-market trade agreed on 22
    May 2015, for a total consideration of $100,375 ($8.03 per ordinary share).
    (2) Acquisition of 6,300 ordinary shares in an on-market trade agreed on 25
    May 2015, for a total consideration of $49,581 ($7.87 per ordinary share).
    
    Ryman Healthcare Limited has a financial products trading policy that
    requires directors to seek prior written clearance from Ryman Healthcare
    Limited for trading by them or by trusts, companies and other entities
    controlled by them during certain closed periods.  Clearance to acquire the
    shares was sought, and was granted in accordance with the policy, on 22 May
    2015.
    
    Summary of other relevant interests after acquisition or disposal
    Class of quoted financial products: N/A
    Nature of relevant interest(s): N/A
    For that relevant interest,--
    (a) number held in class: N/A
    (b) current registered holder(s): N/A
    
    Signature of person authorised to sign on behalf of director or officer
    
    Gordon MacLeod
    Deputy Chief Executive, Chief Financial Officer and Company Secretary
    Ryman Healthcare Limited
    Date of signature: 28 May 2015
    End CA:00264961 For:RYM    Type:RELINT     Time:2015-05-28 16:07:35
    				
 
watchlist Created with Sketch. Add RYM (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.